Nomura Holdings Inc. Sponsored ADR logo

Nomura Holdings Inc. Sponsored ADR (NMR)

Market Closed
17 Jul, 20:00
NYSE NYSE
$
9. 40
-0.39
-3.9837%
$
29.35B Market Cap
24.46 P/E Ratio
- Div Yield
998,300 Volume
0 Eps
$ 9.79
Previous Close
Add Transaction
Day Range
9.29 9.49
Year Range
6.21 10.06
Want to track NMR and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
NMR vs. HOOD: Which Stock Is the Better Value Option?

NMR vs. HOOD: Which Stock Is the Better Value Option?

Investors interested in Financial - Investment Bank stocks are likely familiar with Nomura Holdings (NMR) and Robinhood Markets, Inc. (HOOD). But which of these two stocks is more attractive to value investors?

Zacks | 2 months ago
Are Investors Undervaluing Nomura (NMR) Right Now?

Are Investors Undervaluing Nomura (NMR) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Zacks | 2 months ago
Nomura: IB Could Recover In Ebullient Q1, Macquarie Integration Costs Will Pass

Nomura: IB Could Recover In Ebullient Q1, Macquarie Integration Costs Will Pass

Nomura trades at a notable discount (11x PE) versus global peers, despite solid performances and temporarily depressed income. Temporary acquisition-related costs from the Macquarie deal will pressure profits through the next year, but underlying asset management inflows and alternative AUM growth remain robust. Wholesale and IB segments benefit from Japanese market dynamics, including PBR-related reform from the TSE for the Japan-facing IB businesses.

Seekingalpha | 2 months ago
India flags slower growth, wider deficit as Iran war raises the stakes for New Delhi

India flags slower growth, wider deficit as Iran war raises the stakes for New Delhi

India has warned that its growth forecast of up to 7.4% for the financial year ending March 2027 faces "considerable downside" risk due to the Iran war. The country's chief economic advisor has said that India's "trade deficit will rise significantly," leading to a "widening [of] the current account deficit.

Cnbc | 3 months ago
The Iran war is sending shockwaves through the world's busiest IPO market

The Iran war is sending shockwaves through the world's busiest IPO market

India was the world's busiest IPO market in 2025, but several companies have paused plans to list this year. Global brokerages Nomura and Citi have cut their 2026 target for the Nifty 50 as the Iran war is expected to slow India's economic growth and hurt corporate earnings.

Cnbc | 4 months ago
Options markets are bracing for ‘disaster' as Iran conflict intensifies, Nomura says. Here's how a trader might profit.

Options markets are bracing for ‘disaster' as Iran conflict intensifies, Nomura says. Here's how a trader might profit.

The Iran conflict has sparked tumult in global equity markets, with major indexes in some markets, including South Korea, falling into correction territory.

Marketwatch | 4 months ago
The stock market is still priced for ‘absolute chaos,' but the worst-case scenario will be avoided, Nomura strategist predicts

The stock market is still priced for ‘absolute chaos,' but the worst-case scenario will be avoided, Nomura strategist predicts

Equities are likely to grind sideways but a full-on rout will probably not happen, disappointing those who have been betting on one, Charlie McElligott said.

Marketwatch | 4 months ago
Nomura: Expect the yuan to strengthen only slightly despite multiple tailwinds

Nomura: Expect the yuan to strengthen only slightly despite multiple tailwinds

Nomura North Asia CIO Julia Wang says the Chinese yuan is likely to see only gradual near-term appreciation. She also says greater flexibility is more important than currency strength for any attempts to internationalize the RMB, and that the key thing to watch for at the upcoming Two Sessions is China's fiscal policy plans.

Youtube | 4 months ago
Nomura Value Fund Q4 2025 Portfolio Review

Nomura Value Fund Q4 2025 Portfolio Review

For 4Q2025, Nomura Value Fund institutional Class shares modestly trailed its benchmark, the Russell 1000® Value Index. In October, we sold our position in Kenvue Inc. (KVUE), a consumer health company with globally recognizable brands such as Band-Aid, Listerine, Neutrogena, Tylenol, and Johnson's baby products. Approximately two-thirds of Zoetis's revenue is generated by products for companion animals while the remainder comes from products for livestock.

Seekingalpha | 4 months ago
Nomura Small Cap Value Fund Q4 2025: Performance Drivers And Highlights

Nomura Small Cap Value Fund Q4 2025: Performance Drivers And Highlights

For 4Q25, Nomura Small Cap Value Fund Institutional class shares slightly lagged the return of its benchmark, the Russell 2000 Value Index. Stock selection and an underweight allocation to the healthcare sector were the most notable detractors from the Fund's performance for the quarter. Shares of Herc outperformed during the quarter when the company reported earnings that were better than analysts' expectations.

Seekingalpha | 4 months ago
Nomura Science And Technology Fund Q4 2025 Contributors And Detractors

Nomura Science And Technology Fund Q4 2025 Contributors And Detractors

For 4Q25, Nomura Science and Technology Fund Institutional Class shares had a positive absolute return, but it underperformed S&P North American Technology Sector Index. During the quarter, the underweight to software and services along with an overweight to hardware, semiconductor, and semi cap equipment contributed most. On an individual stock basis, holdings in Seagate Technology, Micron Technology, and an underweight to Oracle were the strongest relative performers.

Seekingalpha | 4 months ago
NMR vs. MKTX: Which Stock Should Value Investors Buy Now?

NMR vs. MKTX: Which Stock Should Value Investors Buy Now?

Investors interested in Financial - Investment Bank stocks are likely familiar with Nomura Holdings (NMR) and MarketAxess (MKTX). But which of these two stocks presents investors with the better value opportunity right now?

Zacks | 4 months ago
Loading...
Load More